Adventa Berhad, an investment holding company, distributes medical and healthcare equipment, appliances, and medical disposal products to hospitals, healthcare centers, and pharmacies. More Details
Flawless balance sheet with weak fundamentals.
Share Price & News
How has Adventa Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ADVENTA is more volatile than 90% of MY stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: ADVENTA's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of MY stocks.
7 Day Return
MY Medical Equipment
1 Year Return
MY Medical Equipment
Return vs Industry: ADVENTA exceeded the MY Medical Equipment industry which returned -60.3% over the past year.
Return vs Market: ADVENTA underperformed the MY Market which returned -0.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Adventa Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StDid You Participate In Any Of Adventa Berhad's (KLSE:ADVENTA) Incredible 308% Return?
1 month ago | Simply Wall StCalculating The Fair Value Of Adventa Berhad (KLSE:ADVENTA)
3 months ago | Simply Wall StIs Adventa Berhad (KLSE:ADVENTA) Using Too Much Debt?
Is Adventa Berhad undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: ADVENTA (MYR1.72) is trading above our estimate of fair value (MYR1.34)
Significantly Below Fair Value: ADVENTA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ADVENTA is unprofitable, so we can't compare its PE Ratio to the MY Medical Equipment industry average.
PE vs Market: ADVENTA is unprofitable, so we can't compare its PE Ratio to the MY market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ADVENTA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ADVENTA is overvalued based on its PB Ratio (4.9x) compared to the MY Medical Equipment industry average (2.6x).
How is Adventa Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Adventa Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Adventa Berhad performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ADVENTA is currently unprofitable.
Growing Profit Margin: ADVENTA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ADVENTA is unprofitable, and losses have increased over the past 5 years at a rate of 65.7% per year.
Accelerating Growth: Unable to compare ADVENTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ADVENTA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.4%).
Return on Equity
High ROE: ADVENTA has a negative Return on Equity (-27.38%), as it is currently unprofitable.
How is Adventa Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: ADVENTA's short term assets (MYR47.9M) exceed its short term liabilities (MYR23.0M).
Long Term Liabilities: ADVENTA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ADVENTA's debt to equity ratio (29.1%) is considered satisfactory.
Reducing Debt: ADVENTA's debt to equity ratio has reduced from 53.2% to 29.1% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable ADVENTA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: ADVENTA is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 10.5% per year.
What is Adventa Berhad current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ADVENTA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ADVENTA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ADVENTA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ADVENTA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ADVENTA is not paying a notable dividend for the MY market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ADVENTA's dividend in 3 years as they are not forecast to pay a notable one for the MY market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Chin Low (61 yo)
Mr. Chin Guan Low serves as the Managing Director and Chief Executive Director of Adventa Berhad. Mr. Low founded Terang Nusa Sdn Bhd in 1988 and served as its Managing Director. Mr. Low serves as the Mana...
CEO Compensation Analysis
Compensation vs Market: Chin's total compensation ($USD144.49K) is about average for companies of similar size in the MY market ($USD130.37K).
Compensation vs Earnings: Chin's compensation has been consistent with company performance over the past year.
Experienced Board: ADVENTA's board of directors are seasoned and experienced ( 17.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Adventa Berhad's company bio, employee growth, exchange listings and data sources
- Name: Adventa Berhad
- Ticker: ADVENTA
- Exchange: KLSE
- Founded: 2003
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: RM262.792m
- Shares outstanding: 152.79m
- Website: https://www.adventa.com.my
- Adventa Berhad
- No. 21, Jalan Tandang 51/205A
- Seksyen 51
- Petaling Jaya
Adventa Berhad, an investment holding company, distributes medical and healthcare equipment, appliances, and medical disposal products to hospitals, healthcare centers, and pharmacies. The company also off...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/30 16:58|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.